Beskrivning
| Land | Finland |
|---|---|
| Lista | First North Finland |
| Sektor | Finans |
| Industri | Investeringar |
Canatu Plc Company Release 9 June 2025 at 9:01 am EEST
Changes in Canatu Plc’s Board of Directors: Scott Sears leaves the board
Scott Sears resigns from the board of directors of Canatu Plc due to commitments to other executive duties. The resignation becomes effective today, June 9th.
Board Chair Timo Ahopelto stated: “I would like to thank Scott Sears for his contributions in steering Canatu’s medical diagnostics business unit, particularly for his insights into unmet clinical needs and his role in shaping the strategy and roadmap.”
Scott Sears commented: “I have greatly appreciated the opportunity to work alongside so many talented professionals. I firmly believe Canatu’s versatile platform technology holds tremendous future potential, and I wish the company continued success moving forward. I’m proud to have played a key role in building a world-class team and am particularly pleased to welcome Nedal Safwat to Canatu. With a strong foundation in place, the time is right for me to leave and focus on other executive responsibilities.“
The company will continue with seven board members until further notice.
Canatu remains strongly committed to the medical diagnostics business and will strengthen its operations in this area in the near future.
Additional information:
Chair of the Board of Directors Timo Ahopelto, timo@lifelineventures.com
Certified Adviser
DNB Carnegie Investment Bank AB (publ), tel. +46 (0)73 856 42 65
About Canatu
Canatu (CANATU, Nasdaq First North, Finland) is a fast-growing deep technology company creating advanced carbon nanotubes (Canatu CNTs), related products, and manufacturing equipment for the semiconductor, automotive, and medical diagnostics industries. Canatu partners with forerunner companies, together transforming products for better tomorrows with nano carbon.
Canatu's versatile platform technology has broad potential applications. Its current core includes CNT membranes for extreme ultraviolet (EUV) processes in the semiconductor industry, enabling the manufacturing of the most advanced chips, as well as film heaters for advanced driver-assistance systems (ADAS) in the automotive industry. Additionally, electrochemical sensors for medical diagnostics are in the development phase. Canatu’s patented CNT reactors and Dry DepositionTM method yield clean and pristine CNTs. The company operates through two business models: selling CNT products directly, as well as selling CNT reactors and licensing the related technology so that customers can produce CNT products under a limited license.
Headquartered in Finland, Canatu also operates in the US, Japan, and Taiwan. Founded in 2004 as a spin-off from Aalto University’s Nanomaterials Group, Canatu currently has around 140 employees representing 35 nationalities, with 20 percent holding or pursuing doctorates. Discover more at www.canatu.com and follow us on LinkedIn.